Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03472586
What this trial is testing

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Study completedNCT00027586
What this trial is testing

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
M.D. Anderson Cancer Center 22
Early research (Phase 1)Study completedNCT00045357
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Active Not RecruitingNCT05598853
What this trial is testing

Intrathecal Double Checkpoint Inhibition

Who this might be right for
Leptomeningeal MetastasisNon-small Cell Lung Cancer Stage IVMelanoma Stage IV
University of Zurich 26
Not applicableEnded earlyNCT02922283
What this trial is testing

IL2 Imaging in Metastatic Melanoma

Who this might be right for
Melanoma
University Medical Center Groningen 19
Testing effectiveness (Phase 2)Ended earlyNCT01590082
What this trial is testing

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 12
Not applicableWithdrawnNCT03205722
What this trial is testing

The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany

Who this might be right for
Melanoma
Bristol-Myers Squibb
Not applicableWithdrawnNCT03161613
What this trial is testing

Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT04809805
What this trial is testing

Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced Cancer

Who this might be right for
Metastatic Melanoma and Other Solid Tumors
Bayer 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286294
What this trial is testing

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

Who this might be right for
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma+3 more
Oslo University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01585194
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal MelanomaStage IV Uveal Melanoma AJCC v7
M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562129
What this trial is testing

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVInoperable Disease
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)Study completedNCT01512251
What this trial is testing

BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma

Who this might be right for
BRAF Mutant Metastatic Melanoma
University of California, San Francisco 8
Testing effectiveness (Phase 2)Study completedNCT00942162
What this trial is testing

Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline 125
Testing effectiveness (Phase 2)Study completedNCT00700882
What this trial is testing

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 81
Testing effectiveness (Phase 2)Study completedNCT00896480
What this trial is testing

Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Study completedNCT00019175
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04655157
What this trial is testing

Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma

Who this might be right for
Melanoma
Jason J. Luke, MD 2
Next Page